The 9 month old child of a diabetic mother presents with tachypnea and hepatomegaly. Echocardiography of the hea showed normal cardiac morphology with asymmetric septal hyperophy. Which of the following you will give to treat this child :
**Question:** The 9 month old child of a diabetic mother presents with tachypnea and hepatomegaly. Echocardiography of the heart showed normal cardiac morphology with asymmetric septal hypertrophy. Which of the following will you give to treat this child:
A. Insulin
B. Beta-blockers
C. ACE inhibitors
D. Aldosterone antagonists
**Correct Answer:** B. Beta-blockers
**Core Concept:**
Asymmetric septal hypertrophy (ASH) is a characteristic finding in children with congenital heart disease, particularly in those with hypertrophic cardiomyopathy (HCM). ASH is a result of increased thickness of the interventricular septum due to myocardial hypertrophy. This condition is associated with increased risk of sudden cardiac death in children, particularly during exercise or when the heart rate is elevated.
**Why the Correct Answer is Right:**
In the given scenario, the child has been diagnosed with hypertrophic cardiomyopathy (HCM) due to the presence of asymmetric septal hypertrophy. Beta-blockers are used in the management of HCM as they:
1. Reduce cardiac output and heart rate, decreasing the workload on the heart.
2. Prevent the development of left ventricular outflow tract obstruction, which is a common complication in HCM.
3. Improve symptoms and reduce the risk of complications, such as heart failure and sudden cardiac death.
**Why Each Wrong Option is Incorrect:**
A. Insulin: Insulin is used in the management of diabetes mellitus, not HCM.
B. Aldosterone antagonists (e.g., spironolactone): These agents are used to target aldosterone excess, which is not relevant in the case of HCM.
C. ACE inhibitors: ACE inhibitors are used in patients with hypertension, heart failure, and diabetic nephropathy, not HCM.
**Clinical Pearl:**
Hypertrophic cardiomyopathy is a condition requiring a comprehensive management plan, including medical therapy, lifestyle modifications, and appropriate referral to a pediatric cardiologist for further evaluation and management. Beta-blockers are a crucial component of the management strategy for HCM.